On Tuesday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $23.17. Bellicum Pharmaceuticals (NASDAQ:BLCM)‘s stock had its “overweight” rating restated by stock analysts at Piper Jaffray in a report issued on Friday. They currently have a $45.00 target price on the stock. Piper Jaffray’s price objective suggests a potential upside of 100.36% from the company’s current price.
Samson Oil & Gas Limited (NYSEMKT:SSN) in last trading activity decreased -11.66% to close at $1.44. Company weekly performance is -20.00% while its quarterly performance stands at -31.43%. Samson Oil & Gas Limited (NYSEMKT:SSN) is -74.74% away from its 52 week high. As previously announced by Samson Oil & Gas Limited (NYSEMKT:SSN) on March 19th, a change in the number of its ordinary shares represented by American Depositary Shares, from 20 ordinary shares per ADS to 200 ordinary shares per ADS, will be effective prior to the commencement of trading on the NYSE MKT on Monday, March 30th, 2015. The change in exchange ratio for the ADSs will have the same effect as a 1-for-10 reverse stock split of the ADSs, reducing the number of outstanding ADSs from 102,900,833 to approximately 10,290,000 ADSs.
Frontier Communications Corporation (NASDAQ:FTR) has 0.50% insider ownership while its institutional ownership stands at 67.50%. In last trading activity company’s stock closed at $7.05. Frontier Communications Corporation (NASDAQ:FTR) plans to release first-quarter 2015 results on Tuesday, May 5, 2015 after the market closes, and to host a conference call that day at 4:30 P.M. Eastern Time.
On Tuesday shares of Neurocrine Biosciences Inc. (NASDAQ:NBIX) closed at $39.71. Company’s EPS growth for next 5 years is recorded as 24.75%. Neurocrine Biosciences Inc. (NASDAQ:NBIX) announced that it has entered into an exclusive collaboration and licensing agreement for the development and commercialization of its VMAT2 inhibitor, NBI-98854, in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation.
Myers Industries Inc. (NYSE:MYE) in last trading activity decreased -0.62% to close at $17.53. Company weekly performance is -3.15% while its quarterly performance stands at 1.10%. Myers Industries Inc. (NYSE:MYE) is -27.10% away from its 52 week high. Myers Industries, Inc. (NYSE:MYE) announced a revision of its previously released financial results for its fourth quarter and year ended December 31, 2014, as a result of completing its Brazilian investigation. The revision as compared to the Company’s earnings release issued February 25, 2015 reflects adjustments which led to an increase in cost of sales of $2.4 million and an increase in selling, general and administrative expenses of $0.1 million for both the fourth quarter and full year of 2014.